Efficacy of the combination of venetoclax and hypomethylating agents in the treatment of patients with primary, relapsed and/or refractory acute myeloid leukemia

Relevance and goals. Treatment of patients with acute myeloid leukemia has traditionally been highly intensive and includes induction therapy using cytarabine and anathracyclines. In addition to new opportunities in the treatment of acute myeloid leukemia, the problem of toxicity of high-intensity t...

詳細記述

書誌詳細

出版年:	Вестник медицинского института «Реавиз»: Реабилитация, врач и здоровье
主要な著者:	E. V. Usikova, K. D. Kaplanov, V. I. Vorob'ev, T. I. Lobanova, M. A. Ul'yanova, D. G. Kisilichina, Yu. N. Kobzev, D. I. Shikhbabaeva, O. Yu. Vinogradova, V. V. Ptushkin
フォーマット:	論文
言語:	ロシア語
出版事項:	Private institution educational organization of higher education "Medical University "ReaViz" 2023-01-01
主題:	acute myeloid leukemia hypomethylating agents venetoclax efficacy and overall survival analysis hematological toxicity infectious complications covid-19
オンライン･アクセス:	https://vestnik.reaviz.ru/jour/article/view/565